✦ LIBER ✦

Radioimmunolocation of metastases from adenocarcinoma of the colon: Using a hepatoma antibody

✍ Scribed by Chaitanya R. Divgi; Alfred M. Cohen

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 265 KB
Volume: 11
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840110528

No coin nor oath required. For personal study only.

✦ Synopsis

Radioimmunolocation of hepatic and pulmonary metastasis of human colon adenocarcinoma. Gastroenterology 1989

📜 SIMILAR VOLUMES

Visualization of metastases from colon c

Visualization of metastases from colon carcinoma using an lodine 131-radiolabeled monoclonal antibody

✍ Michael J. Leyden; Christopher H. Thompson; Meir Lichtenstein; John T. Andrews; 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 569 KB

The clinical utility of the Das-1 monocl

The clinical utility of the Das-1 monoclonal antibody in identifying adenocarcinoma of the colon metastatic to the liver in fine-needle aspiration tissue

✍ Zimmerman, Robert L. ;Das, Kiron M. ;Burke, Melissa A. ;Young, Nancy A. ;Solomid 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

## Background: The cytologic diagnosis of adenocarcinoma in a liver mass usually is straightforward. identifying where the adenocarcinoma arose from is much more problematic. the das-1 immunostain is directed against a colon specific antigen and has shown excellent sensitivity and specificity for a

Investigation of the Interactions betwee

Investigation of the Interactions between β-Lactams and a Metallo-β-lactamase from Bacillus cereus Using a Monoclonal Antibody

✍ S.J. Chambers; G.M. Wyatt; M.R.A. Morgan 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 175 KB

A monoclonal antibody recognizing the active site of a ␤-lactamase from Bacillus cereus was identified and characterized. The binding of the monoclonal antibody to the active site was quantitatively inhibited by a broad spectrum of ␤-lactam antibiotics. The levels of inhibition were found to be asso

Infectious complications of monoclonal a

Infectious complications of monoclonal antibodies used in cancer therapy : A systematic review of the evidence from randomized controlled trials

✍ Petros I. Rafailidis; Ourania K. Kakisi; Konstantinos Vardakas; Matthew E. Falag 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract The introduction of monoclonal antibodies (MoAbs) into the treatment of cancer has led to improvements in patient survival. However, to the authors' knowledge, little attention has been paid to the infectious complications associated with their use. The authors performed a systematic re

A comparison of the choice of monoclonal

A comparison of the choice of monoclonal antibodies for recovery of fetal cells from maternal blood using FACS for noninvasive prenatal diagnosis of hemoglobinopathies

✍ Edna D'Souza; Kanjaksha Ghosh; Roshan Colah 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 2 views

Temporal trends in the proportion cured

Temporal trends in the proportion cured for cancer of the colon and rectum: A population-based study using data from the Finnish Cancer Registry

✍ Paul C. Lambert; Paul W. Dickman; Pia Österlund; Therese Andersson; Risto Sankil 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 418 KB 👁 1 views

## Abstract Colorectal cancer is the third most common cancer worldwide and the second most common cancer in Europe. Cumulative relative survival curves for both cancer of the colon and cancer of the rectum generally plateau after ∼6–8 years. When this occurs, “population” or “statistical” cure is